Cell Penetrating Peptide Market to grow with a CAGR of 9.47% through 2028

Rising adoption of peptides in pharmaceutical and consumer healthcare are expected to drive the Global Cell Penetrating Peptide Market growth in the forecast period, 2024-2028.

According to TechSci Research report, “Cell Penetrating Peptide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global Cell Penetrating Peptide Market stood at USD 133.33 Million in 2022 and is anticipated to grow at an impressive rate of around 9.47% in the forecast period, 2024-2028. The market for Cell Penetrating Peptide devices has witnessed consistent growth over the Rising Demand for Targeted Drug Delivery. The versatility of CPPs has led to their adoption in a wide range of therapeutic areas, including oncology, neurodegenerative diseases, infectious diseases, and regenerative medicine. As research continues to uncover novel applications, the market is benefiting from a growing pipeline of CPP-based therapies. Recent developments in peptide synthesis techniques and chemical modification strategies have enabled the design of CPPs with improved stability, specificity, and delivery efficiency.

These advancements have boosted the development of next-generation CPPs, further propelling market growth. The global prevalence of chronic diseases, such as cancer and cardiovascular disorders, continues to rise. CPPs offer a promising avenue for the delivery of innovative therapies that can address unmet medical needs in these disease areas, driving market growth. The trend toward personalized medicine, where treatments are tailored to individual patient characteristics, has led to increased interest in targeted drug delivery methods like CPPs. These peptides can be engineered to selectively deliver therapeutics to specific cell types or tissues, aligning with the principles of personalized medicine.

Also, owing to stringent regulations and the high cost of outsourcing can hamper the growth of Global Cell Penetrating Peptide Market. Similarly, a lack of skilled professionals can restrain the growth of Global Cell Penetrating Peptide Market. Additionally, Limited Clinical Data will further restrict the growth of Global Cell Penetrating Peptide Market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell Penetrating Peptide Market.”

The Global Cell Penetrating Peptide Market is segmented into Type, Application, End user and Region.

Based on End User, Global Cell Penetrating Peptide market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals, and Clinics. The Pharmaceutical and Biotechnology Companies segment accounted for the largest revenue share in 2022 and is expected to exhibit a rapid CAGR over the forecast period. This can be attributed to the increasing usage of peptides in pharmaceutical companies. Pharmaceutical companies drive CPP-based therapies through clinical trial phases and navigate the complex regulatory landscape. Their expertise in designing and conducting clinical trials is essential for demonstrating safety, efficacy, and compliance with regulatory requirements. Pharmaceutical and biotechnology companies also contribute to educational initiatives, conferences, and workshops focused on CPPs. These platforms facilitate knowledge sharing, promote scientific discourse, and encourage the development of a skilled workforce.

Major companies operating in Global Cell Penetrating Peptide Market are:

• The Cupid Peptide Company.
• AltaBioscience Ltd.
• AnaSpec Inc.
• Amidebio LLC
• Biopeptide Co LLC
• AAPPTec
• CSBio Company Inc
• CEM Corporation
• Bachem Holding AG

In MAY 2022, Bristol Myers Squibb and LOTTE Corporation stated that LOTTE has decided to acquire Bristol Myers Squibb's East Syracuse, New York-based production plant. The East Syracuse location will house LOTTE's novel biologics CDMO business in the U.S. In February 2022, Amgen and Plexium, Inc. revealed a multi-year research collaboration and license agreement to generate new targeted protein degradation therapeutics for previously difficult drug targets.

In March 2023, Ono Pharmaceuticals and PeptiDream entered into a collaboration for the drug discovery and development of Macrocyclic Constrained Peptide Therapeutics.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The North America region is expected to witness significant growth of Global Cell Penetrating Peptide market due to the rising R&D spending by key players. North America stands out as a dominant force, driving substantial growth and innovation. The region's leadership is attributed to a convergence of factors that foster an environment conducive to CPP advancements. North America boasts a robust biotechnology and pharmaceutical industry, characterized by extensive research infrastructure, strategic investments, and a culture of innovation. Furthermore, strong collaborations between academia, research institutions, and industry players have propelled the development of novel CPP-based therapies. Access to a skilled talent pool and favorable regulatory frameworks has expedited clinical translation and commercialization. With a focus on personalized medicine and a penchant for cutting-edge technologies, North America's contribution to CPP research, development, and market expansion remains a key driver in shaping the future of this dynamic field. Increasing demand from life sciences, biotechnology, and food & beverages industries is the major factor driving the growth of the global Cell Penetrating Peptide Market during the forecast period” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Cell Penetrating Peptide Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Protein-based CPPs, Peptide-based CPPs), By Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, Others (Vaccine development, Antimicrobial Therapy), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals, and Clinics), By Region and Competition”, has evaluated the future growth potential of Global Cell Penetrating Peptide Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Cell Penetrating Peptide Market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com